Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase NA 2Phase 2/3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 1Mucositis 1

Interventions

Cyclophosphamide 143pembrolizumab 126Nivolumab 114Carboplatin 99Dexamethasone 93Rituximab 91Paclitaxel 87Gemcitabine 85Lenalidomide 75Cytarabine 74Radiotherapy 72Cisplatin 70Bevacizumab 64Etoposide 62fludarabine phosphate 58fludarabine 56Docetaxel 54Bortezomib 54Ipilimumab 53Prednisone 49Doxorubicin 48Temozolomide 47Everolimus 46Erlotinib Hydrochloride 46Fluorouracil 44Azacitidine 44Capecitabine 43Calcium Dobesilate 43Filgrastim 42Melphalan 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Has results × Curcumin × Clear all
NCT02300727 2019-05-31

Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy

Aurora BayCare Medical Center

Phase 1/2 Terminated
6 enrolled 4 charts
Other

Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡